“On an average, we have deployed about $3 billion every year and we see enough opportunity to continue doing that,” he said, detailing that the bulk of the capital invested in FY26 was in follow-on opportunities. Historically, the investment firm has made follow-on investments in companies such as CureFit Healthcare, Cartrade, Manipal, Cloudnine and Licious.
Temasek widens India bets as portfolio swells to $42 billion
Date:

